Your great discoveries start here
400 Pinnacle Way, STE 430 Norcross, GA 30071
ISO 13485:2016 certified cGMP Compliant Manufacturing Facility
CBI offers and extensive array of assay design and development services including:
Let the CBI Research and Development Team design and develop molecular solutions for identifying your biomarkers of interest according to our strict adherence to cGMP / ISO / GLP standards.
CBI produces and conjugates all of its own antibodies. Each antibody is rigorously validated specifically for flow cytometry applications in an ISO9001 / ISO 13485 certified facility. CBI conjugates FITC; PE; PerCP; APC; Biotin; PerCP-Cyanine 5.5; PE- Cyanine 7, APC-Cyanine 7 and a variety of other fluorophores. Recently, CBI has partnered with AAT Bioquest®, a producer of fluorescent labeling dyes to offer a unique high-performance solution for immunophenotyping and immunomonitoring.
iFluor™ dyes span the full UV-visible-IR spectrum. iFluor™ dyes have improved labeling performance compared to the classic fluorescent labeling dyes such as FITC, TRITC, Texas Red® and cyanine dyes
mFluor™ dyes span the full UV-visible spectrum and designed to be maximally excited by one of the major light sources in flow cytometers such as the violet laser at 405 nm or blue laser at 488 nm.
Monoclonal antibody design and development is lending researchers the opportunity to create highly specific, customizable mAbs for both RUO and ASR purposes. Start with a free consultation and let us take it to the step of your choosing.
Choose the production quantity that best meets your needs:From Idea to Antibody
Thank you for your interest in our products! To guarantee product integrity, orders placed after 1pm EST may be processed the next business day. Dismiss
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.